Literature DB >> 14982935

Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats.

Yi Wen1, Shaohua Yang, Ran Liu, Anne Marie Brun-Zinkernagel, Peter Koulen, James W Simpkins.   

Abstract

Aberrant mitosis occurs in many tauopathy-related neurodegenerative diseases and is believed to precede the formation of neurofibrillary tangles. In this study, we report for the first time that transient cerebral ischemia induces aberrant mitotic proteins and hyperphosphorylation of tau protein with neurofibrillary tangle-like conformational epitopes in adult female rat cortex. Following transient cerebral ischemia in rats, initiation of apoptosis precedes and is potentially integrated with subsequent aberrant mitosis and tau hyperphosphorylation. Furthermore, inhibition of mitosis-related cyclin-dependent kinases (Cdks) by roscovitine significantly reduced the hyperphosphorylation of tau. Administration of the female sex steroid and potent neuroprotective agent, 17beta-estradiol, reduced ischemia-reperfusion-induced cerebral damage and the subsequent aberrant mitosis and tauopathies. These results provide a neuropathological basis for the higher prevalence of dementia in stroke patients and support the hypothesis that apoptosis and aberrant mitosis are integrated pathological events in neurons that may play a critical role in the development of Alzheimer's disease and other tauopathy-related neuropathology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14982935     DOI: 10.1074/jbc.M311768200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

Review 1.  Estrogen neuroprotection and the critical period hypothesis.

Authors:  Erin Scott; Quan-guang Zhang; Ruimin Wang; Ratna Vadlamudi; Darrell Brann
Journal:  Front Neuroendocrinol       Date:  2011-11-04       Impact factor: 8.606

2.  Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms.

Authors:  Cathy Andorfer; Christopher M Acker; Yvonne Kress; Patrick R Hof; Karen Duff; Peter Davies
Journal:  J Neurosci       Date:  2005-06-01       Impact factor: 6.167

Review 3.  Role of cell cycle proteins in CNS injury.

Authors:  Kimberly R Byrnes; Alan I Faden
Journal:  Neurochem Res       Date:  2007-04-03       Impact factor: 3.996

4.  Cell cycle activation and CNS injury.

Authors:  Bogdan A Stoica; Kimberly R Byrnes; Alan I Faden
Journal:  Neurotox Res       Date:  2009-04-21       Impact factor: 3.911

5.  Cognitive Impairment and Brain and Peripheral Alterations in a Murine Model of Intraventricular Hemorrhage in the Preterm Newborn.

Authors:  Antonio Segado-Arenas; Carmen Infante-Garcia; Isabel Benavente-Fernandez; Daniel Sanchez-Sotano; Juan Jose Ramos-Rodriguez; Almudena Alonso-Ojembarrena; Simon Lubian-Lopez; Monica Garcia-Alloza
Journal:  Mol Neurobiol       Date:  2017-07-28       Impact factor: 5.590

6.  Cdk5 phosphorylates Cdh1 and modulates cyclin B1 stability in excitotoxicity.

Authors:  Carolina Maestre; Maria Delgado-Esteban; Jose C Gomez-Sanchez; Juan P Bolaños; Angeles Almeida
Journal:  EMBO J       Date:  2008-09-25       Impact factor: 11.598

7.  Reduced early hypoxic/ischemic brain damage is associated with increased GLT-1 levels in mice expressing mutant (P301L) human tau.

Authors:  Guanghong Liao; Miou Zhou; Simon Cheung; James Galeano; Nam Nguyen; Michel Baudry; Xiaoning Bi
Journal:  Brain Res       Date:  2008-11-01       Impact factor: 3.252

8.  Attenuating the DNA damage response to double-strand breaks restores function in models of CNS neurodegeneration.

Authors:  Richard I Tuxworth; Matthew J Taylor; Ane Martin Anduaga; Alaa Hussien-Ali; Sotiroula Chatzimatthaiou; Joanne Longland; Adam M Thompson; Sharif Almutiri; Pavlos Alifragis; Charalambos P Kyriacou; Boris Kysela; Zubair Ahmed
Journal:  Brain Commun       Date:  2019-07-02

Review 9.  Non-feminizing estrogens: a novel neuroprotective therapy.

Authors:  Ashley B Petrone; Joshua W Gatson; James W Simpkins; Miranda N Reed
Journal:  Mol Cell Endocrinol       Date:  2014-01-11       Impact factor: 4.102

10.  Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Rationale and recommendations for first evaluating anti-Alzheimer's disease medications in acute brain injury patients.

Authors:  James W Simpkins; Joshua W Gatson; Jane G Wigginton
Journal:  Alzheimers Dement       Date:  2009-03       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.